EA
CNMD icon

Evolution Advisers’s CONMED CNMD Stock Holding History

Evolution Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+3
New +$108 ﹤0.01% 351

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Evolution Advisers's CNMD Position: Q2 2026 in Review

Evolution Advisers opened a new position in CONMED (CNMD) in Q2 2026: 3 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #351 among its holdings.

246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Evolution Advisers held 3 shares of CONMED worth $0 as of Q2 2026.
  • CONMED was a new Evolution Advisers position in Q2 2026.
  • CONMED made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #351 holding.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.